Skip to main navigation Skip to search Skip to main content

The Intratumoral Distribution of Radiolabeled 177Lu-BR96 Monoclonal Antibodies Changes in Relation to Tumor Histology over Time in a Syngeneic Rat Colon Carcinoma Model.

Anders Örbom, Sophie Eriksson, Erika Elgström, Tomas G Ohlsson, Rune Nilsson, Jan Tennvall, Sven-Erik Strand

Research output: Contribution to journal › Article › peer-review

282 Downloads (Pure)

Abstract

The therapeutic effect of radioimmunotherapy depends on the distribution of the absorbed dose in relation to viable cancer cells within the tumor, which in turn is a function of the activity distribution. The aim of this study was to investigate the distribution of (177)Lu-DOTA-BR96 monoclonal antibodies targeting the Lewis Y antigen over 7 d using a syngeneic rat model of colon carcinoma.
Original languageEnglish
Pages (from-to)1404-1410
JournalJournal of Nuclear Medicine
Volume54
Issue number8
DOIs
Publication statusPublished - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Subject classification (UKÄ)

  • Radiology and Medical Imaging

Fingerprint

Dive into the research topics of 'The Intratumoral Distribution of Radiolabeled 177Lu-BR96 Monoclonal Antibodies Changes in Relation to Tumor Histology over Time in a Syngeneic Rat Colon Carcinoma Model.'. Together they form a unique fingerprint.

Cite this